Toxicological response of the model fungus Saccharomyces cerevisiae to different concentrations of commercial graphene nanoplatelets by Suarez-Diez, Maria et al.
1Scientific RepoRtS |         (2020) 10:3232  | https://doi.org/10.1038/s41598-020-60101-7
www.nature.com/scientificreports
toxicological response of the model 
fungus Saccharomyces cerevisiae 
to different concentrations 
of commercial graphene 
nanoplatelets
Maria Suarez-Diez1, Santiago porras2, felix Laguna-teno3, peter J. Schaap1 &  
Juan A. tamayo-Ramos3*
Graphene nanomaterials have attracted a great interest during the last years for different applications, 
but their possible impact on different biological systems remains unclear. Here, an assessment to 
understand the toxicity of commercial polycarboxylate functionalized graphene nanoplatelets (Gn) 
on the unicellular fungal model Saccharomyces cerevisiae was performed. While cell proliferation was 
not negatively affected even in the presence of 800 mg L−1 of the nanomaterial for 24 hours, oxidative 
stress was induced at a lower concentration (160 mg L−1), after short exposure periods (2 and 4 hours). 
no DnA damage was observed under a comet assay analysis under the studied conditions. in addition, 
to pinpoint the molecular mechanisms behind the early oxidative damage induced by Gn and to identify 
possible toxicity pathways, the transcriptome of S. cerevisiae exposed to 160 and 800 mg L−1 of Gn 
was studied. Both GN concentrations induced expression changes in a common group of genes (337), 
many of them related to the fungal response to reduce the nanoparticles toxicity and to maintain cell 
homeostasis. Also, a high number of genes were only differentially expressed in the GN800 condition 
(3254), indicating that high GN concentrations can induce severe changes in the physiological state of 
the yeast.
Graphene and derived nanomaterials (GFNs) are of great interest for different industrial applications, and cur-
rently hundreds of companies produce commercial GFNs worldwide1,2. In the same line, many research programs 
have been launched at global scale, aiming to achieve foundational breakthroughs in the generation of scientific 
knowledge and the development of new technologies around these 2D carbon derived nanomaterials. For exam-
ple, the European Union (EU) started the Graphene Flagship research program in 2013, with a total budget of 1 
billion Euros, being one of the largest research initiatives ever deployed in Europe.
Given the impact that new developments based on graphene are expected to have on future industry world-
wide, it is necessary that any possible unwanted societal impacts and risks related to them are determined. 
Considering the increasing applications, there is a growing likelihood of GFNs release into the environment, 
which could lead to human and ecosystem exposure with potentially harmful effects. For this reason, the iden-
tification of possible safety issues related to the generation, utilisation and disposal of graphene-based materials 
is essential. Toxicological analyses are also necessary in view of their possible biomedical and biotechnological 
applications3,4. Attending to the morphological and physical properties of this carbon derived nanomaterial, the 
potential risks to the health of animals, humans and the environment are clear5. Most of the studies focusing on 
graphene biological applications, nanosafety, and in the determination of underlying toxicity mechanisms have 
been done on mammal cell lines and laboratory animals4,6,7. These studies have been essential to obtain insights 
on how GFNs interact with biological systems and biomolecules for different applications, and to understand 
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factors determining their toxicity, which have been found to be different depending on the animals or cell models 
used, the administration routes, or the physicochemical properties of the selected nanomaterials. In these stud-
ies, several typical mechanisms underlying GFN toxicity have been revealed, for instance, physical destruction, 
induction of oxidative stress, DNA damage, inflammatory response, apoptosis, autophagy, and necrosis6–8.
In relation to studies investigating the biological impact of GFNs on microbial systems, many publications 
have reported the antibacterial properties of different graphene derivatives and composites9–13. In case of the 
interactions between fungi and graphene-based materials, most of the efforts have focused on improving the 
antifungal properties of GFNs through their modification with antimycotic drugs, peptides or metals14–17. Also, 
applications involving the fungus Saccharomyces cerevisiae and graphene derivatives have been investigated by 
interfacing graphene oxide and yeast cells18–20, aiming for future applications where the cellular physiology can be 
integrated with electrical read outs21, and for the development of environmentally friendly-cost effective method-
ologies for the preparation of surface modified graphene19. However, very little is known about the specific fungal 
response to the presence of graphene in the environment, such as possible physiological changes or the induction 
of toxicity pathways.
Determining the eliciting factors of nanoparticles toxicity in a certain microbial system requires a joint phys-
icochemical and biological approach22. Therefore, in this work we combined a thorough characterization of a 
commercial sample of polycarboxylate functionalized graphene nanoplatelets (GN), with a set of physiological 
analyses in S. cerevisiae and the study of the microorganism global transcriptional response to the presence of 
the nanomaterial. The introduction of polycarboxylate groups in graphitic structures increases the hydrophilicity 
of the surface and the dispersibility of the nanomaterial in polar solvents23, which could enhance the contact 
between the nanomaterial and the fungal cell, that being the reason for the choice of GN in the present study. 
Also, S. cerevisiae is one of the most widely used eukaryotic models to understand basic molecular processes in 
humans and other higher eukaryotes, it is an extraordinary workhorse for fermentation-based industrial applica-
tions, and is increasingly used for the toxicity assessment of substances, such as synthetic chemicals, heavy metals 
and engineered nanomaterials24–30. This study evaluates the toxicity of different GN concentrations for the yeast 
S. cerevisiae, through the analysis of cell viability, cytotoxicity, genotoxicity, and global transcriptional response.
Results and Discussion
characteristics of the selected commercial polycarboxylate functionalized graphene nano-
platelets. The association between a certain biological response with the chemical and morphological prop-
erties of graphene requires an appropriate characterization of the product. The fate of graphene nanomaterials 
when exposed to biological systems is determined both by their intrinsic physicochemical characteristics such as 
lateral dimensions, thickness, and C/O ratio/functionalization and by their acquired characteristics upon contact 
with the biological environment, such as the biocorona31. In case of the selected commercial polycarboxylate 
functionalized graphene nanoplatelets (GN), in a recent study from our research group (Anton et al. 2018)32, it 
was determined that in contrast to graphene oxide, its ability to interact with biomolecules was very low. Also, the 
physical-chemical properties of GN were determined in the same study32. The product used by Anton et al. (2018) 
was exactly that used for this work (Sigma-Aldrich; ref: 806625; lot: MKBW5736V), therefore, the insights previ-
ously determined on its characteristics and properties are highly valuable for the present toxicology assessment. 
Microscopy analyses using AFM and TEM instruments showed that GN flakes were of variable size and appeared 
to be stacked in clusters from micrometric to nanometric scale. Also, diverse analytical techniques (ATR-FTIR, 
Raman, X-ray diffraction and XPS) were applied to understand the GN structure and composition. According 
to the XPS analysis, the material showed to have a very high carbon content (relative atomic composition close 
to 96%), with an oxygen composition of around 3.4%. In this regard, the presence of polycarboxylate groups, or 
any other oxygen containing functional groups could not be inferred from the ATR-FTIR spectra analysis, which 
suggests that their presence in the commercial product is neglectable. In fact, the dispersibility of the nanoparti-
cles in water suspensions was low. Therefore, we did not consider the possible presence of carboxylic groups in the 
product during our toxicology assessment. Although the described analyses gave us good insights into the mor-
phology and composition of this particular lot of commercial GN (ref: 806625; lot: MKBW5736V), none of these 
analytical techniques allowed the identification and quantification of trace elements32. However, since the pres-
ence of trace metal impurities in graphene derivatives, either contained in the graphite precursor or transferred 
by reactants used in the nanomaterial preparation, has been previously described33–38, a trace element analysis of 
GN was done by inductively coupled plasma mass spectrometry (ICP-MS) to fully characterize its composition. 
All metallic elements identified and their concentrations are displayed in Table 1.
A number of metallic elements, previously described as possible graphene contaminants, were identified37–39, 
such as silicon (323.63 ppm), iron (276.03 ppm), manganese (6.18 ppm), cobalt (0.92 ppm), copper (2.89 ppm), 
molybdenum (6.17 ppm) and nickel (34.41 ppm). The presence of K and Na is usual as well in graphene syn-
thesis procedures based on chemical oxidation of graphite and subsequent thermal or chemical reduction37,38. 
The concentrations of most of the different elements identified in GN are relatively low, however, the presence 
of multi-metals should be carefully considered, due to the possible induction of mixture toxicity in biological 
systems directly exposed to the nanomaterial40.
Determination of colony forming units S. cerevisiae cells exposed to different GN concentrations. 
The viability of S. cerevisiae cells exposed to two GN concentrations (160 and 800 mg L−1) and exposure times 
(2 and 24 h) was assessed through colony forming units (CFU) determination. The concentrations selected to 
assess the biological impact of GN on yeast cells were based on previous concentration ranges used by other 
authors in recent studies, where the impact of distinct graphene derivatives on fungal species was studied41–44. 
Also, a previous study provided toxicology data at transcriptomics level by exposing S. cerevisiae to 160 mg L−1 45, 
so we considered interesting to use the mentioned concentration to assess and compare the toxicological response 
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of the fungus to both nanoparticle types. Together with 160 mg L−1, we also decided to study the response of 
the fungus to a significantly higher concentration (5 times higher: 800 mg L−1), to compare the yeast response 
between two clearly contrasting conditions.
As displayed in Fig. 1, no differences in viability were observed in the selected exposure conditions. Therefore, 
the selected GN seem to have low toxicity towards S. cerevisiae, being at least lower than that reported for other 
carbon nanomaterials, such as 2D-graphene oxide (GO), 1D-multi-walled carbon nanotubes (MWCNTs) or 
1D-oxidized single-walled carbon nanotubes (O-SWCNTs), which induced significant yeast growth inhibition 
ppm
Al 2.17 ± 0.25
B 20.53 ± 7.20
Ba 9.03 ± 0.80
Ce 0.23 ± 0.02
Co 0.92 ± 0.07
Cr 62.85 ± 4.46
Cu 2.89 ± 0.60
Fe 276.03 ± 21.87
K 56800.80 ± 2143.97
Mg 11.95 ± 0.36
Mn 6.18 ± 0.37
Mo 6.17 ± 0.49
Na 730.53 ± 40.97
Nb 0.017 ± 0.002
Nd 0.016 ± 0.004
Ni 34.41 ± 2.54
Pr 0.007 ± 0.000
Pb 0.635 ± 0.043
Rb 8.23 ± 0.41
Si 323.63 ± 79.63
Sr 0.12 ± 0.03
V 0.084 ± 0.005
W 0.96 ± 0.38
Zr 0.335 ± 0.007
Table 1. Composition of GN determined by ICP-MS. The reported values are the averages of two independent 
sample analyses.
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Figure 1. Colony forming units (CFUs) determination of S. cerevisiae cells exposed to 160 and 800 mg L−1 of 
GN during 2 hours (a) and 24 hours (b). The control condition corresponds to non-exposed S. cerevisiae cells. 
The reported values are the averages of three biological replicates per culture condition.
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at lower concentrations (160, 400 and 188.2 mg L−1 respectively)41,44,46,47. The impact of 0D-fullerene nanoparti-
cles (nC60) exposure to S. cerevisiae was also studied, with no apparent effect on the growth yield of the fungus, 
although the nC60 concentration used (31 mg L−1) was lower than that used in the previously described studies48. 
The shape of carbon derived nanomaterials is a relevant characteristic influencing their interaction with biologi-
cal molecules and organisms. However, other physicochemical features of carbon derived nanomaterials such as 
the chemical composition, size, stability, functionalization, charge, porosity and hydrophobicity/hydrophilicity, 
agglomeration or aggregation, also affect their reactivity49, making thus difficult to predict their toxicological 
potential in a particular organism by only considering their morphology.
The influence of graphene derivatives on the viability of other fungi has been little studied. Recently, two stud-
ies reported the impact of graphene oxide and reduced graphene oxide on the filamentous fungus Phanerochaete 
chrysosporium, with the latter compound showing lower toxicity for the fungus than the former42,43. Besides 
carbon nanomaterials, the toxicological impact on S. cerevisiae of various metal oxide nanoparticles have been 
evaluated as well, generally showing low toxicity50–52.
Determination of oxidative stress. To evaluate whether GN were able to induce oxidative stress in S. cer-
evisiae, cells growing at exponential phase were exposed to 160 mg L−1 of the nanomaterial, for 2 and 4 hours. As 
shown in Fig. 2, the oxidative stress levels were significantly increased in S. cerevisiae in the presence of the carbon 
derived nanoparticle. Reactive oxygen species (ROS) levels were significantly higher 2 hours after the exposure 
started, but also remained significantly higher than in the negative control at 4 hours. Carbon derived nanomate-
rials have shown previously to induce oxidative stress in yeast. In case of GO and O-SWCNT, similar concentra-
tions to the one tested here also induced ROS, but the exposure time tested in both cases was 24 hours, while no 
clear evidence of ROS formation was observed for yeast cells exposed to MWCNT41,46,47. In a more recent study, 
the induction of oxidative stress in yeast at short exposure periods (2 and 4 hours) by different commercial GO 
products was also determined44.
Determination of genotoxic effect. The possible genotoxic effect of the selected GN on S. cerevisiae cells 
was determined following a standard protocol previously described53. GN concentrations higher than 80 mg L−1 
could not be tested using the described methodology, as the cell nuclei could not be properly visualized under 
the fluorescence microscope. Therefore, the potential genotoxic effect of GN on S. cerevisiae spheroplasts was 
determined at 80 mg L−1. At least 450 comets per condition were analysed, and the parameters tail DNA, tail 
moment and olive tail moment, previously applied in similar studies done in S. cerevisiae54,55, were calculated to 
estimate the genotoxic potential of GN. As it can be observed in Fig. 3, no significant differences in any of the 
three parameters were observed between the negative control and the conditions were S. cerevisiae was exposed 
to the graphene nanoparticles.
Results obtained in the colony forming units, oxidative stress and genotoxicity analyses indicate that, while 
high concentrations of GN (up to 800 mg L−1) at long exposure periods of time (up to 24 hours) were not able to 
reduce S. cerevisiae cells viability, the nanoparticles could provoke oxidative stress at early culture stages (2 hours) 
and at a lower concentration (at least 160 mg L−1), while no signs of induced genotoxicity were observed in the 
selected conditions. The observation of ROS production without an apparent impact on cell viability is not rare, 
however both oxidative stress and viability loss are usually observed for graphene derivatives in similar exposure 
experiments41,44,56–58.
transcriptional response of S. cerevisiae cells to different GN concentrations. Having into con-
sideration the above presented results, a transcriptomics experiment was performed to assess the early response 
(2 hours) of S. cerevisiae cells exposed to different GN concentrations (160 and 800 mg L−1). The aim of this exper-
iment was to understand the early response of yeast to this type of carbon nanoparticle, for which no similar 
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Figure 2. Oxidative stress (ROS) determination of S. cerevisiae cells exposed to 160 mg L−1 of GN during 2 
and 4 hours. The control condition corresponds to non-exposed S. cerevisiae cells. The reported values are the 
averages of two biological replicates per culture condition.
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studies have been reported so far. Additionally, we also wanted to pinpoint the molecular mechanisms behind the 
early oxidative damage induced by GN to identify possible toxicity pathways.
Differently to what was observed in previous studies for GO41, the ability of GN to bind RNA was very low, so 
it was possible to isolate total RNA from S. cerevisiae cells exposed to this type of nanomaterial without having to 
introduce a particle-cells separation process. After RNA isolation, the integrity of the purified ribonucleic acids 
was analyzed through an agarose gel based visualization analysis, and by analyzing the samples with a bioanalyzer 
(Agilent 2100). RNA-Seq analysis was done using the Illumina sequencing system (further details can be found 
in the Materials and Methods section). Once the RNA-Seq reads were obtained and mapped to the S. cerevisiae 
BY4741 strain genome, information regarding the mapping status could be visualized (Supplementary Table S1). 
In all cases, the amount of total reads that mapped the S. cerevisiae genome ranged between 91.3 and 93.5%. This 
result, together with the total reads obtained for each of the samples and the fact that around 87.7% to 92.7% of 
the reads mapped to exonic regions in the genome, gave a good indication about the high quality of the RNA 
generated in this experiment.
After read mapping and normalization, Principal Component Analysis (PCA) was used to represent the var-
iability between samples and among biological replicates. The results show that the samples clustered together in 
a condition specific manner, with only minor variations between the independent biological replicates (Fig. 4). 
The GN800 condition displayed higher levels of transcriptomic change condition compared to GN160 in relation 
)b)a c)
C - C +
GN
 80
 m
g L
0
5
1 0
1 5
C - C +
0
2
4
6
8
C - C +
0
2
4
6
8
Ta
il 
D
N
A
 %
-1
GN
 80
 m
g L
-1
Ta
il 
m
om
en
t
O
liv
e 
ta
il 
m
om
en
t
GN
 80
 m
g L
-1
Figure 3. Comet assay for DNA damage analysis on S. cerevisiae cells through the quantification of tail DNA 
% (a), tail moment (b) and olive tail moment (c) parameters in non-exposed cells (negative control; C−), cells 
exposed to 10 mM of H2O2 (positive control; C+) and cells exposed to 80 mg L−1 of GN. The reported values are 
the averages of three biological replicates per culture condition.
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Figure 4. Principal Component Analysis (PCA) plot of the biological replicates of transcripts from three 
different exposure conditions to polycarboxylate functionalized graphene nanoplatelets (non-exposed, 
160 mg L−1 and 800 mg L−1).
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to the control condition, as evident in the separation of the samples along PC1, which explains a large part (95%) 
of the variance in the data.
Regarding the differential expression of genes between GN160 vs C and GN800 vs C (Supplementary 
Table S2), volcano plots were obtained (Fig. 5). We only consider as differentially expressed with a biological 
meaning those genes with a difference in expression higher than 1.5-fold (corresponding to 0.585 log2 FC) and 
p-value (after correction for multiple testing) lower than 0.05. As it can be observed in Fig. 5, the number of dif-
ferentially expressed genes in S. cerevisiae was widely different. In the presence of 160 mg L−1 of GN, 339 genes 
were differentially expressed between the exposed and non-exposed cells, while cells exposed to a GN concentra-
tion 5 times higher (800 mg L−1) had 3591 differentially expressed genes. Therefore, the number of genes showing 
altered expression specifically in the presence of 800 mg L−1 of GN was much higher, showing that the presence 
of a higher concentration of the nanomaterial induces a stronger transcriptional response in S. cerevisiae. In both 
GN-exposed conditions, most of the genes showing significant changes in their expression levels were downregu-
lated. This was particularly remarkable in case of the GN160 condition, where 313 out of the observed 339 differ-
entially expressed genes were downregulated. Both GN concentrations induced expression changes in a common 
group of genes (337), while a high number of genes were only differentially expressed in the GN800 condition 
(3254). It is interesting to remark that virtually all genes that showed a significant expression change in GN160, 
were also differentially regulated in GN800 as well (337 out of 339 genes).
In relation to the biological processes which show an altered functionality in the conditions where S. cerevisiae 
was exposed to different GN concentrations, a Gene Ontology59,60 enrichment and a KEGG (Kyoto Encyclopedia 
of Genes and Genomes)61 pathway enrichment analysis of differentially expressed genes was done. Results of the 
enrichments in categories related to biological process (BP), molecular function (MF) and cellular component 
(CC) are provided in the supplementary material (Supplementary Table S3).
Metabolic pathway enrichment also highlights the upregulation of genes associated to core metabolic pro-
cesses such as synthesis and utilisation of sugars, amino acids, lipids, organic acids, hormones, etc. Table 2 sum-
marizes the significant pathways enriched in the up and down regulation of genes upon both exposures (full 
results can be found in Supplementary Table S4).
Amongst the common significantly upregulated genes in the two exposure conditions (26) some associated to 
increased sugar metabolism were found, although the relatively low number of genes associated to this biological 
process precluded additional analysis. Four genes were associated to the term GO 0042221 (“response to toxin”): 
YNL134C, YDR533C (HSP31), YKR076W (ECM4) and YOL151W (GRE2). The gene with accession number 
YNL134C is a NADH-dependent aldehyde reductase, involved in detoxification of furfural, with a broad substrate 
specificity62; Hsp31p is a heat-shock stress response protein, which confers protection against reactive oxygen 
species63; ECM4 codes for a cell wall glutathione transferase whose expression has been shown to be upregulated 
upon exposure to genotoxic agents, such as methyl methanesulfonate, cisplatin and bleomycin64; and GRE2 codes 
for a 3-methylbutanal reductase and NADPH-dependent methylglyoxal reductase, whose expression is positively 
affected by oxidative stress, and it is regulated by the HOG pathway, a mitogen-activated protein kinase (MAPK) 
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Figure 5. Volcano plots displaying the amount of differentially expressed genes and fold change (log2) in 
expression levels in GN160 (a) and GN800 (b) conditions when compared to the control condition. Genes were 
considered differentially expressed if FC > 1.5 (upregulated) or FC < 1/1.5 (downregulated) and false discovery 
rate (FDR) was lower than 0.05.
7Scientific RepoRtS |         (2020) 10:3232  | https://doi.org/10.1038/s41598-020-60101-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
pathway mainly related to hyperosmotic stress response in S. cerevisiae65. Additional genes having a function 
related to oxidation-reduction processes (YCR102C, YLR460C, YML131W, YJL052W (TDH1)) were upregu-
lated too in GN160 and GN800 compared to the control: YCR102C, YLR460C and YML131W belong to the 
medium-chain dehydrogenase/reductase (MDR) family, which includes metabolic enzymes acting on alcohols or 
aldehydes, with possible roles in detoxifying alcohols and related compounds, protecting against environmental 
stresses such as osmotic shock, reduced or elevated temperatures, or oxidative stress66, while TDH1 codes for 
a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) isozyme, whose expression is regulated by reductive 
stress caused by an excess of cytoplasmic NADH67. Detailed inspection of the results also showed upregula-
tion of YDL085W (NDE2) in the presence of both GN concentrations, although the change has a FDR slightly 
above the selected threshold (FDR = 0.057). This gene codes for a mitochondrial external NADH dehydroge-
nase involved in providing the cytosolic NADH to the mitochondrial respiratory chain68. The multidrug efflux 
pump coding gene YML116W (ATR1), which confers resistance to aminotriazole, 4-nitroquinoline-N-oxide and 
Size
Commonly upregulated genes 
(GN160 and GN800) vs Control 
(26 genes)
GN800 upregulated genes vs Control 
(1578 genes)
# in sample p-value FDR # in sample p-value FDR
Glycolysis/Gluconeogenesis 56 3 0.001 0.008 33 2.58E-09 4.13E-08
Citrate cycle (TCA cycle) 32 0 NA NA 21 1.58E-07 2.21E-06
Pentose phosphate pathway 28 0 NA NA 15 0.000 0.002
Fructose and mannose metabolism 23 2 0.003 0.015 10 0.018 0.057
Galactose metabolism 25 2 0.004 0.015 9 0.081 0.161
Steroid biosynthesis 17 0 NA NA 9 0.005 0.023
Alanine, aspartate and glutamate metabolism 32 0 NA NA 16 0.000 0.003
Glycine, serine and threonine metabolism 31 0 NA NA 15 0.001 0.007
Cysteine and methionine metabolism 40 0 NA NA 20 9.58E-05 0.001
Valine, leucine and isoleucine degradation 13 0 NA NA 10 4.06E-05 0.000
Valine, leucine and isoleucine biosynthesis 12 1 0.043 0.072 9 0.000 0.001
Lysine biosynthesis 12 0 NA NA 8 0.001 0.007
Arginine and proline metabolism 21 0 NA NA 10 0.009 0.036
Phenylalanine, tyrosine and tryptophan 
biosynthesis 17 0 NA NA 11 0.000 0.001
beta-Alanine metabolism 13 0 NA NA 7 0.012 0.042
Glutathione metabolism 25 0 NA NA 11 0.012 0.042
Starch and sucrose metabolism 41 2 0.010 0.022 22 1.01E-05 0.000
Other types of O-glycan biosynthesis 13 0 NA NA 7 0.012 0.042
Amino sugar and nucleotide sugar metabolism 33 2 0.006 0.020 15 0.002 0.012
Glycerophospholipid metabolism 38 0 NA NA 15 0.012 0.042
alpha-Linolenic acid metabolism 3 0 NA NA 3 0.011 0.042
Pyruvate metabolism 43 3 0.000 0.008 24 1.55E-06 1.74E-05
Propanoate metabolism 13 1 0.046 0.072 7 0.012 0.042
Butanoate metabolism 9 0 NA NA 6 0.005 0.023
Methane metabolism 26 0 NA NA 13 0.002 0.009
2-Oxocarboxylic acid metabolism 35 1 0.120 0.138 21 1.41E-06 1.74E-05
Biosynthesis of amino acids 121 2 0.071 0.095 72 7.77E-16 2.18E-14
MAPK signaling pathway – yeast 114 1 0.343 0.343 55 5.37E-10 1.00E-08
Mitophagy - yeast 41 0 NA NA 17 0.004 0.020
Hippo signaling pathway - multiple species 8 0 NA NA 6 0.002 0.011
Commonly downregulated genes 
(GN160 and GN800) vs Control 
(311 genes)
GN800 downregulated genes vs Control 
(2013 genes)
Oxidative phosphorylation 72 7 0.0379 0.2877 33 0.0011 0.0179
Ribosome 183 19 0.0004 0.0076 116 2.22E-16 2.26E-14
RNA polymerase 30 6 0.0017 0.0211 14 0.0241 0.2727
Spliceosome 79 12 0.0002 0.0057 36 0.0007 0.0179
Proteasome 35 1 0.7932 0.9699 19 0.0010 0.0179
Protein export 22 2 0.2515 0.7326 15 0.0001 0.0058
Endocytosis 74 6 0.1055 0.5011 34 0.0008 0.0179
Table 2. Metabolic pathway enrichment analysis. Size indicates number of genes in the genome assigned to 
the pathway, whereas #in sample refer to the considered set. Only pathways with FDR < 0.05 in some of the sets 
have been kept. NA indicates not available.
8Scientific RepoRtS |         (2020) 10:3232  | https://doi.org/10.1038/s41598-020-60101-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
5-fluorouracil69,70, and whose expression has been found to increase during DNA-replication stress70, was also 
found to be upregulated in both GN160 and GN800. This was also the case for the endochitinase coding gene 
YLR286C (CTS1), involved in cell separation71, and the genes YCL040W (GLK1) and YFR053C (HXK1), related 
to carbohydrate metabolic process. The above described genes, upregulated in the presence of lower (160 mg L−1) 
and higher (800 mg L−1) GN concentrations, are the core response activated by S. cerevisiae, whose overexpres-
sion can be associated to a fungal response to reduce the nanoparticles toxicity and to maintain cell homeostasis.
Regarding the common significantly downregulated genes in both exposure conditions, most of them are 
related to cell cycle, protein complex biogenesis, ribosome biogenesis and RNA processing and metabolism. 
Previous toxicology studies in S. cerevisiae have observed a significant downregulation of ribosomal biogenesis 
and assembly genes in response to different stresses72–74 and the same has been reported in case of RNA process-
ing genes75.
As mentioned earlier, exposing S. cerevisiae to the higher GN concentration induced a very strong transcrip-
tional response of the fungus. The number of specifically upregulated genes in the presence of 800 mg L−1 of GN 
was very high (1578), and this produced changes in many different gene networks. Many of the transcriptional 
changes occurred in metabolic genes, related to the synthesis and utilisation of sugars, amino acids, lipids and 
key metabolic process related to energy and redox balances such as the TCA cycle or the pentose phosphate 
pathway (see Table 2). A group of upregulated genes showed the same behaviour when S. cerevisiae cells were 
exposed to other nanocarbon derivatives, suggesting the existence of a common biological response to different 
nanomaterials. For instance, the superoxide dismutase genes SOD1 (YJR104C) and SOD2 (YHR008C), which 
play a role in oxygen radical detoxification, and YCA1 (YOR197W), involved in apoptosis regulation, were found 
to be upregulated too when yeast cells were exposed to different MWCNTs concentrations46. Additionally, several 
iron transport and metabolism related genes (YHL040C (ARN1), YOR382W (FIT2), YOR383C (FIT3), YER145C 
(FTR1), YMR058W (FET3) and YOR384W (FRE5)) were also overexpressed in the presence of graphene oxide45. 
GO was reported to induce the disruption of yeast iron-related physiological and metabolic processes when pres-
ent in the environment at 160 mg L−1 45, but we did not observe the same biological response when using the same 
concentration of GN. However, based on our observations, GN could cause extracellular iron deficiency as well 
in yeast when present in higher concentrations (800 mg L−1). In fact, besides the mentioned iron utilisation genes, 
a high number of additional ORFs related to metal ion transport and homeostasis showed significantly higher 
expression levels in GN800, indicating that high concentrations of the nanomaterial reduce the bioavailability of 
metallic elements for the fungus. Considering these observations and the metals and metalloids concentration 
determined in GN by ICP-MS, the possibility that the selected nanomaterials exert metal induced toxicity on S. 
cerevisiae is low.
The pathway enrichment analysis does not allow to distinguish between amino acid biosynthesis and uti-
lization, as many enzymes are involved in both processes. However detailed inspection of the genes suggests 
increased degradation in the GN800 condition. For instance, the arginine related regulator YMR042W (ARG80) 
and its targets, the arginine catabolic genes YPL111W (CAR1) and YLR438W (CAR2)76, appear upregulated in 
the presence of 800 mg L−1 of GN. The increased amino acid degradation is consistent with the reduced expres-
sion of genes associated to translation and protein synthesis.
We also observed an activation of the glutamate dehydrogenase (GDH) pathway, indicated by the upregulation 
of the ammonia permease coding gene YGR121C (MEP1), YOR375C (GDH1) and YOR375C (GDH3), coding for 
two NADP-dependent GDH isoforms for glutamate synthesis, and the glutamine synthase (GS) gene YPR035W 
(GLN1), and for the reduced expression of YDL215C (GDH2), another NADP-dependent GDH responsible for 
glutamate degradation. The GDH pathway is known to be regulated by the quality and availability of nitrogen 
and carbon sources77. Upon exposure to 800 mg L−1 of GN, two of the main regulators of the nitrogen catabolite 
repression (NCR) pathway, YFL021W (GAT1) and YER040W (GLN3) appear overexpressed as well as two of the 
main regulators associated to sugar catabolite repression (YGL035C) MIG1 and (YGL035C) GAL80. The GDH 
pathway is also related to response to stress, as GDH3 is needed for resistance to ROS stress induced apoptosis78. 
The GDH pathway leads to glutamate synthesis which is the starting point for gamma-glutamylcysteine and 
glutathione synthesis. The analysis shows a significant enrichment in genes in the glutathione synthesis pathway. 
Gamma-glutamylcysteine and glutathione are potent antioxidants79, so the upregulation of this pathway further 
indicates a general response to counteract possible oxidative stress induced by the high GN concentration.
Also, changes related to cell reproduction, filamentous growth and cell aggregation were observed. These 
changes indicate that high GN concentrations induce severe changes in the physiological state of the yeast. The 
fact that many upregulated genes are related to “aging” (29), could indicate that higher concentrations of GN 
induce early senescence or cell death. Also, fact that many genes related to osmotic stress (35) and membrane 
invagination (57), indicate that the presence of high GN concentrations suppose an environmental thread for the 
stability and integrity of the fungus.
conclusion
The toxicity assessment of commercial polycarboxylate functionalized graphene nanoplatelets using the model 
fungus S. cerevisiae has unveiled the potential impact of this type of nanomaterial to rapidly alter the physio-
logical state of the yeast. Overall, GN showed to have low lethal toxicity levels for S. cerevisiae, although it was 
capable to induce oxidative stress at the lower concentration tested, indicating the potential of the nanomaterial 
to provoke cellular damage. The analysis of the transcriptional landscape of S. cerevisiae cells exposed to different 
GN concentrations indicated that the yeast was forced to induce detoxification and oxidative stress responses in 
the presence of the nanomaterial, and severe changes in its physiological state were observed too. The reported 
results contribute to the understanding of the molecular mechanisms underlying yeast-graphene interactions, 
which could influence the performance of applications based on interfacing cells with the nanomaterial, and give 
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an indication of the exposure risk of unicellular eukaryotic organisms. Also, the reported results highlight the 
complexity of microbial systems-graphene interactions.
Methods
Materials, reagents and strains. Most of the chemicals and reagents were purchased to Sigma-Aldrich 
and Acros Organics. In particular, the polycarboxylate functionalized graphene nanoplatelets (ref: 806625; lot: 
MKBW5736V) were purchased to Sigma-Aldrich. The S. cerevisiae BY4741 strain was purchased to Thermo 
Fisher. Yeast cells were grown and maintained in standard liquid YPD medium (1% yeast extract, 1% yeast bac-
to-peptone, 2% glucose). Cell cultures in liquid media were kept on a rotary shaker at 185 rpm at 30 °C.
icp-MS. Metals and metalloids content in GN were determined following the protocol reported by Domi 
et al. (2020) with minor changes44. Graphene samples (0.1 g) were subjected to a digestion process with 7 mL of 
HNO3 Suprapur (Merck) (65% v/v) and 1 ml of H2O2 (30% v/v), while being subjected to the following thermal 
treatment: a temperature gradient from room temperature up to 80 °C in 4 minutes, followed by a second temper-
ature gradient, from 80 °C to 120 °C in 4 minutes, and by a third temperature gradient, from 120 °C to 190 °C in 
5 minutes. Then, temperature was kept constant at 190 °C for 30 minutes, and finally samples were cooled down 
for 1 hour. The analysis of digested samples was done with an Agilent 8900 ICP-QQQ instrument.
Determination of oxidative stress. Intracellular levels of reactive oxygen species (ROS) were determined 
using the reagent CM-H2DCFDA, following a protocol similar to that reported by James et al. (2015)80. S. cere-
visiae cells growing in exponential phase were pelleted, washed and incubated with CM-H2DCFDA (7 μM) in 
PBS for 60 minutes, at 30 °C and 185 rpm. Afterwards, yeast cells were washed again, resuspended in YPD and 
subsequently exposed to the GN nanomaterial (160 mg L−1) for 2 and 4 hours. Then, yeast cells were washed two 
times with PBS, incubated 2 minutes in a solution containing AcLi 2 M, and subsequently washed and incubated 
again for 2 minutes in a solution containing SDS (0.01%) and chloroform (0.4%). Finally, cells were pelleted and 
the supernatant was transferred to a black opaque 96 micro-well plate, where fluorescence was measured using a 
microplate reader (BioTek Synergy HT, excitation wavelength, 485 nm; emission wavelength 528 nm).
Yeast comet assay. The yeast comet assay was done following the protocol published by Oliveira and 
Johansson (2012)81. Yeast spheroplasts were exposed to 80 mg L−1 of GN during 40 minutes at 4 °C. Three biologi-
cal replicates were analysed per culture condition. A Leica DMI6000 B inverted fluorescence microscope was used 
to analyse the obtained microgels, to visualize and register the yeast comets. At least 150 comets were registered 
per biological replicate and subsequently analysed with the open access software CASP82.
RnA isolation, quality control and sequencing. RNA isolation was performed using Thermo Fisher 
Scientific reagents, following the TRIzol Plus RNA Purification Kit user guide (Pub. No. MAN0000561), with minor 
modifications41,83. Briefly, yeast aliquots were pelleted by centrifugation (13000 g) and subsequently resuspended 
in 1 mL of TRIzol reagent in a 2 mL tube, prefilled with glass beads (MP). Yeast samples were disrupted using a 
FastPrep-24 Instrument (MP). After disruption, 200 µL of chloroform were added and the mix was homogenated 
for 10 seconds. The mix was poured into Phasemaker tubes (2 mL), and centrifuged at 13000 g in a table-top centri-
fuge83. The RNA present in the water phase was purified using the PureLink RNA Mini Kit (Thermo), following the 
manufacturer’s instructions. RNA integrity was assessed with an Agilent 2100 system, and only high quality samples 
(RIN value ≥8) were selected for whole transcriptome shotgun sequencing83. Total RNA was sent for whole tran-
scriptome sequencing to Novogene Bioinformatics Technology Co. Ltd. (HongKong, China). mRNA sequencing 
(RNA-Seq) was performed using Ilumina Hiseq. 4000 and the Casava pipeline version 1.8.2.
RnA-Seq data processing and analysis. Reads were pre-processed using FastqPuri for quality control 
and adapter, contamination and quality filtering84. Reads with adapter contamination were removed, as well 
as the ones with 50% of the bases with quality below 20. Also, reads with a percentage of unidentified bases 
greater than 10% were also removed. Latest assembly of the reference genome for this strain was retrieved from 
Ensembl85, genome accession number (GCA_000146045.2). Reads were mapped to the genome using Star v2.786. 
The genome was indexed specifying the read length to improve accuracy. The mapping was done using two 
pass method. Number of reads for each genome feature were retrieved using featureCounts87. Total number of 
reads are summarized in the supplementary material (Supplementary Table S1). Data have been submitted to the 
European Nucleotide Archive and can be found under the accession number PRJEB33532.
Read counts per gene were normalized and differential expression was computed using DESeq. 2 v 1.2488, with 
default parameters except for the alpha threshold that was set to 0.05. Variance stabilizing transformation con-
sidering the experimental design was performed using the ‘vst’ command prior to principal component analysis 
(PCA). Enrichment analysis for selected groups of genes were performed using the hypergeometric function to 
model the background probability and the Benjamini–Hochberg procedure was used to control the false dis-
covery rate (FDR) and correct for multiple testing. Gene ontology (GO) enrichment analysis was performed 
using the BINGO Cytoscape app (v 3.0.3)89. Annotation to be used with BINGO was downloaded from the Gene 
Ontology59,60. For the metabolic pathway enrichment analysis, gene to pathway associations were retrieved from 
KEGG61,90, and all genes in the genome were used as a background set. Statistical manipulations and graphical 
representations of the data were performed using R (v 3.6.1)91, and the packages ggplot2 (v3.2.0) 92. Further infor-
mation related to the identified differentially expressed genes was obtained using The Saccharomyces Genome 
Database (SGD)93.
Received: 24 September 2019; Accepted: 22 January 2020;
Published: xx xx xxxx
1 0Scientific RepoRtS |         (2020) 10:3232  | https://doi.org/10.1038/s41598-020-60101-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
References
 1. Bianco, A. Graphene: Safe or toxic? the two faces of the medal. Angewandte Chemie - International Edition 52, 4986–4997 (2013).
 2. Kauling, A. P. et al. The Worldwide Graphene Flake Production. Advanced Materials 30, 1803784 (2018).
 3. Tadyszak, K., Wychowaniec, J. K. & Litowczenko, J. Biomedical Applications of Graphene-Based Structures. Nanomaterials (Basel, 
Switzerland) 8, (2018).
 4. Singh, D. P. et al. Graphene oxide: An efficient material and recent approach for biotechnological and biomedical applications. 
Materials Science and Engineering: C 86, 173–197 (2018).
 5. Arvidsson, R., Boholm, M., Johansson, M. & de Montoya, M. L. “Just Carbon”: Ideas About Graphene Risks by Graphene 
Researchers and Innovation Advisors. Nanoethics 12, 199–210 (2018).
 6. Ou, L. et al. Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms. Particle and fibre toxicology 
13, 57 (2016).
 7. Ema, M., Gamo, M. & Honda, K. A review of toxicity studies on graphene-based nanomaterials in laboratory animals. Regulatory 
Toxicology and Pharmacology 85, 7–24 (2017).
 8. Sanchez, V. C., Jachak, A., Hurt, R. H. & Kane, A. B. Biological Interactions of Graphene-Family Nanomaterials: An Interdisciplinary 
Review. Chemical Research in Toxicology 25, 15–34 (2012).
 9. Karahan, H. E. et al. Antimicrobial graphene materials: the interplay of complex materials characteristics and competing 
mechanisms. Biomaterials Science 6, 766–773 (2018).
 10. Zarafu, I. et al. Antimicrobial Features of Organic Functionalized Graphene-Oxide with Selected Amines. Materials 11, 1704 (2018).
 11. Zhao, R. et al. Highly Stable Graphene-Based Nanocomposite (GO–PEI–Ag) with Broad-Spectrum, Long-Term Antimicrobial 
Activity and Antibiofilm Effects. ACS Applied Materials & Interfaces 10, 17617–17629 (2018).
 12. Jaworski, S. et al. Graphene Oxide-Based Nanocomposites Decorated with Silver Nanoparticles as an Antibacterial Agent. Nanoscale 
Research Letters 13, 116 (2018).
 13. Li, N. et al. Powerful antibacterial activity of graphene/nanoflower-like nickelous hydroxide nanocomposites. Nanomedicine 13, 
2901–2916 (2018).
 14. Li, C. et al. The antifungal activity of graphene oxide–silver nanocomposites. Biomaterials 34, 3882–3890 (2013).
 15. Farzanegan, A. et al. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin 
and Graphene oxide against disseminated candidiasis. Journal de Mycologie Médicale 28, 628–636 (2018).
 16. Ficociello, G. et al. Anti-Candidal Activity and In Vitro Cytotoxicity Assessment of Graphene Nanoplatelets Decorated with Zinc 
Oxide Nanorods. Nanomaterials (Basel, Switzerland) 8 (2018).
 17. Asadi Shahi, S., Roudbar Mohammadi, S., Roudbary, M. & Delavari, H. A new formulation of graphene oxide/fluconazole 
compound as a promising agent against Candida albicans. Progress in biomaterials 8, 43–50 (2019).
 18. Yang, S. H. et al. Interfacing Living Yeast Cells with Graphene Oxide Nanosheaths. Macromolecular Bioscience 12, 61–66 (2012).
 19. Khanra, P. et al. Simultaneous bio-functionalization and reduction of graphene oxide by baker’s yeast. Chemical Engineering Journal 
183, 526–533 (2012).
 20. Valentini, L., Bittolo Bon, S., Signetti, S. & Pugno, N. M. Graphene-Based Bionic Composites with Multifunctional and Repairing 
Properties. ACS Applied Materials & Interfaces 8, 7607–7612 (2016).
 21. Kempaiah, R., Chung, A. & Maheshwari, V. Graphene as Cellular Interface: Electromechanical Coupling with Cells. ACS Nano 5, 
6025–6031 (2011).
 22. Kubacka, A. et al. Understanding the antimicrobial mechanism of TiO2-based nanocomposite films in a pathogenic bacterium. 
Scientific Reports 4, 4134 (2015).
 23. Wu, J. et al. Polycarboxylation of carbon nanofibers under Friedel–Crafts condition: A simple route to direct binding of carboxylic 
functionalities to graphitic π-system. Chemical Physics Letters 552, 78–83 (2012).
 24. Bao, S., Lu, Q., Fang, T., Dai, H. & Zhang, C. Assessment of the toxicity of CuO nanoparticles by using Saccharomyces cerevisiae 
mutants with multiple genes deleted. Applied and Environmental Microbiology 81, 8098–8107 (2015).
 25. Mager, W. H. & Winderickx, J. Yeast as a model for medical and medicinal research. Trends in Pharmacological Sciences 26, 265–273 
(2005).
 26. Duina, A. A., Miller, M. E. & Keeney, J. B. Budding Yeast for Budding Geneticists: A Primer on the Saccharomyces cerevisiae Model 
System. Genetics 197, 33–48 (2014).
 27. Mattanovich, D., Sauer, M. & Gasser, B. Yeast biotechnology: teaching the old dog new tricks. Microbial Cell Factories 13, 34 (2014).
 28. Nomura, T. et al. Exposure of the Yeast Saccharomyces cerevisiae to Functionalized Polystyrene Latex Nanoparticles: Influence of 
Surface Charge on Toxicity. Environmental Science & Technology 47, 3417–3423 (2013).
 29. Kitagawa, E., Momose, Y. & Iwahashi, H. Correlation of the Structures of Agricultural Fungicides to Gene Expression in 
Saccharomyces cerevisiae upon Exposure to Toxic Doses. https://doi.org/10.1021/ES026156B (2003).
 30. Kasemets, K., Käosaar, S., Vija, H., Fascio, U. & Mantecca, P. Toxicity of differently sized and charged silver nanoparticles to yeast 
Saccharomyces cerevisiae BY4741: a nano-biointeraction perspective. Nanotoxicology 13, 1041–1059 (2019).
 31. Fadeel, B. et al. Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment. ACS Nano 12, 
10582–10620 (2018).
 32. Antón-Millán, N. et al. Influence of Three Commercial Graphene Derivatives on the Catalytic Properties of a Lactobacillus 
plantarum α- l -Rhamnosidase When Used as Immobilization Matrices. ACS Applied Materials & Interfaces 10, 18170–18182 
(2018).
 33. Ambrosi, A. et al. Chemically reduced graphene contains inherent metallic impurities present in parent natural and synthetic 
graphite. Proceedings of the National Academy of Sciences of the United States of America 109, 12899–904 (2012).
 34. Lupina, G. et al. Residual Metallic Contamination of Transferred Chemical Vapor Deposited Graphene. ACS Nano 9, 4776–4785 
(2015).
 35. Lisi, N. et al. Contamination-free graphene by chemical vapor deposition in quartz furnaces. Scientific Reports 7, 9927 (2017).
 36. Ye, R. et al. Manganese deception on graphene and implications in catalysis. Carbon 132, 623–631 (2018).
 37. Wong, C. H. A. et al. Synthetic routes contaminate graphene materials with a whole spectrum of unanticipated metallic elements. 
Proceedings of the National Academy of Sciences of the United States of America 111, 13774–9 (2014).
 38. Mazánek, V. et al. Ultrapure Graphene Is a Poor Electrocatalyst: Definitive Proof of the Key Role of Metallic Impurities in Graphene-
Based Electrocatalysis. ACS Nano, https://doi.org/10.1021/acsnano.8b07534 (2019).
 39. Jalili, R. et al. Silicon as a ubiquitous contaminant in graphene derivatives with significant impact on device performance. Nature 
Communications 9, 5070 (2018).
 40. Mesquita, V. A., Silva, C. F. & Soares, E. V. Toxicity Induced by a Metal Mixture (Cd, Pb and Zn) in the Yeast Pichia kudriavzevii: The 
Role of Oxidative Stress. Current Microbiology 72, 545–550 (2016).
 41. Zhu, S., Luo, F., Zhu, B. & Wang, G.-X. Toxicological effects of graphene oxide on Saccharomyces cerevisiae. Toxicology research 6, 
535–543 (2017).
 42. Yang, H. et al. Influence of reduced graphene oxide on the growth, structure and decomposition activity of white-rot fungus 
Phanerochaete chrysosporium. RSC Advances 8, 5026–5033 (2018).
 43. Xie, J. et al. Toxicity of graphene oxide to white rot fungus Phanerochaete chrysosporium. Chemosphere 151, 324–331 (2016).
 44. Domi, B. et al. Interaction Analysis of Commercial Graphene Oxide Nanoparticles with Unicellular Systems and Biomolecules. 
International Journal of Molecular Sciences 21, 205 (2019).
1 1Scientific RepoRtS |         (2020) 10:3232  | https://doi.org/10.1038/s41598-020-60101-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
 45. Yu, Q. et al. Graphene oxide significantly inhibits cell growth at sublethal concentrations by causing extracellular iron deficiency. 
Nanotoxicology 11, 1102–1114 (2017).
 46. Zhu, S. et al. Toxicological effects of multi-walled carbon nanotubes on Saccharomyces cerevisiae: The uptake kinetics and 
mechanisms and the toxic responses. Journal of Hazardous Materials 318, 650–662 (2016).
 47. Zhu, S., Luo, F., Li, J., Zhu, B. & Wang, G.-X. Biocompatibility assessment of single-walled carbon nanotubes using Saccharomyces 
cerevisiae as a model organism. Journal of Nanobiotechnology 16, 44 (2018).
 48. Hadduck, A. N., Hindagolla, V., Contreras, A. E., Li, Q. & Bakalinsky, A. T. Does aqueous fullerene inhibit the growth of 
saccharomyces cerevisiae or escherichia coli? Applied and Environmental Microbiology 76, 8239–8242 (2010).
 49. Madannejad, R. et al. Toxicity of carbon-based nanomaterials: Reviewing recent reports in medical and biological systems. Chemico-
Biological Interactions 307, 206–222 (2019).
 50. Kasemets, K., Ivask, A., Dubourguier, H.-C. & Kahru, A. Toxicity of nanoparticles of ZnO, CuO and TiO2 to yeast Saccharomyces 
cerevisiae. Toxicology in Vitro 23, 1116–1122 (2009).
 51. Kasemets, K., Suppi, S., Künnis-Beres, K. & Kahru, A. Toxicity of CuO Nanoparticles to Yeast Saccharomyces cerevisiae BY4741 
Wild-Type and Its Nine Isogenic Single-Gene Deletion Mutants. Chemical Research in Toxicology 26, 356–367 (2013).
 52. García-Saucedo, C., Field, J. A., Otero-Gonzalez, L. & Sierra-Álvarez, R. Low toxicity of HfO2, SiO2, Al2O3 and CeO2 nanoparticles 
to the yeast, Saccharomyces cerevisiae. Journal of Hazardous Materials 192, 1572–1579 (2011).
 53. Oliveira, R. & Johansson, B. Quantitative DNA damage and repair measurement with the yeast comet assay. Methods in Molecular 
Biology 920, 101–109 (2012).
 54. Rank, J., Syberg, K. & Jensen, K. Comet assay on tetraploid yeast cells. Mutation Research/Genetic Toxicology and Environmental 
Mutagenesis 673, 53–58 (2009).
 55. Bayat, N., Rajapakse, K., Marinsek-Logar, R., Drobne, D. & Cristobal, S. The effects of engineered nanoparticles on the cellular 
structure and growth of Saccharomyces cerevisiae. Nanotoxicology 8, 363–73 (2014).
 56. Ou, L. et al. The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and 
programmed necrosis. International journal of nanomedicine 12, 6633–6646 (2017).
 57. Chang, Y. et al. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicology Letters 200, 201–210 (2011).
 58. Mittal, S. et al. Physico-chemical properties based differential toxicity of graphene oxide/reduced graphene oxide in human lung 
cells mediated through oxidative stress. Scientific Reports 6, 39548 (2016).
 59. Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nature Genetics 25, 25–29 (2000).
 60. The Gene Ontology Consortium. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Research 47, 
D330–D338 (2019).
 61. Kanehisa, M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research 28, 27–30 (2000).
 62. Zhao, X. et al. YNL134C from Saccharomyces cerevisiae encodes a novel protein with aldehyde reductase activity for detoxification 
of furfural derived from lignocellulosic biomass. Yeast 32, 409–422 (2015).
 63. Skoneczna, A., Micialkiewicz, A. & Skoneczny, M. Saccharomyces cerevisiae Hsp31p, a stress response protein conferring protection 
against reactive oxygen species. Free Radical Biology and Medicine 42, 1409–1420 (2007).
 64. Caba, E., Dickinson, D. A., Warnes, G. R. & Aubrecht, J. Differentiating mechanisms of toxicity using global gene expression analysis 
in Saccharomyces cerevisiae. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 575, 34–46 (2005).
 65. Garay-Arroyo, A. & Covarrubias, A. A. Three genes whose expression is induced by stress inSaccharomyces cerevisiae. Yeast 15, 
879–892 (1999).
 66. Nordling, E., Jörnvall, H. & Persson, B. Medium-chain dehydrogenases/reductases (MDR). Family characterizations including 
genome comparisons and active site modeling. European journal of biochemistry 269, 4267–76 (2002).
 67. Ansell, R. et al. NADH-reductive stress in Saccharomyces cerevisiae induces the expression of the minor isoform of glyceraldehyde-
3-phosphate dehydrogenase (TDH1). Current Genetics 45, 90–95 (2004).
 68. Luttik, M. A. et al. The Saccharomyces cerevisiae NDE1 and NDE2 genes encode separate mitochondrial NADH dehydrogenases 
catalyzing the oxidation of cytosolic NADH. The Journal of biological chemistry 273, 24529–34 (1998).
 69. Gömpel-Klein, P. & Brendel, M. Allelism of SNQ1 and ATR1, genes of the yeast Saccharomyces cerevisiae required for controlling 
sensitivity to 4-nitroquinoline-N-oxide and aminotriazole. Current genetics 18, 93–6 (1990).
 70. Carlsson, M., Hu, G.-Z. & Ronne, H. Gene dosage effects in yeast support broader roles for the LOG1, HAM1 and DUT1 genes in 
detoxification of nucleotide analogues. PloS one 13, e0196840 (2018).
 71. Lesage, G. & Bussey, H. Cell wall assembly in Saccharomyces cerevisiae. Microbiology and molecular biology reviews: MMBR 70, 
317–43 (2006).
 72. Yu, L. et al. Microarray analysis of p-anisaldehyde-induced transcriptome of Saccharomyces cerevisiae. Journal of Industrial 
Microbiology & Biotechnology 37, 313–322 (2010).
 73. Soontorngun, N. Reprogramming of nonfermentative metabolism by stress-responsive transcription factors in the yeast 
Saccharomyces cerevisiae. Current Genetics 63, 1–7 (2017).
 74. Bereketoglu, C., Arga, K. Y., Eraslan, S. & Mertoglu, B. Genome reprogramming in Saccharomyces cerevisiae upon nonylphenol 
exposure. Physiological Genomics 49, 549–566 (2017).
 75. Bergkessel, M., Whitworth, G. B. & Guthrie, C. Diverse environmental stresses elicit distinct responses at the level of pre-mRNA 
processing in yeast. RNA (New York, N.Y.) 17, 1461–78 (2011).
 76. Ljungdahl, P. O. & Daignan-Fornier, B. Regulation of Amino Acid, Nucleotide, and Phosphate Metabolism in Saccharomyces 
cerevisiae. Genetics 190, 885–929 (2012).
 77. Mara, P., Fragiadakis, G. S., Gkountromichos, F. & Alexandraki, D. The pleiotropic effects of the glutamate dehydrogenase (GDH) 
pathway in Saccharomyces cerevisiae. Microbial Cell Factories 17, 170 (2018).
 78. Lee, Y. J., Kim, K. J., Kang, H. Y., Kim, H.-R. & Maeng, P. J. Involvement of GDH3 -encoded NADP+ -dependent Glutamate 
Dehydrogenase in Yeast Cell Resistance to Stress-induced Apoptosis in Stationary Phase Cells. Journal of Biological Chemistry 287, 
44221–44233 (2012).
 79. Grant, C. M., MacIver, F. H. & Dawes, I. W. Glutathione synthetase is dispensable for growth under both normal and oxidative stress 
conditions in the yeast Saccharomyces cerevisiae due to an accumulation of the dipeptide gamma-glutamylcysteine. Molecular 
Biology of the Cell 8, 1699–1707 (1997).
 80. James, J. et al. A rapid method to assess reactive oxygen species in yeast using H 2 DCF-DA. Analytical. Methods 7, 8572–8575 
(2015).
 81. Oliveira, R. & Johansson, B. Quantitative DNA Damage and Repair Measurement with the Yeast Comet Assay. in. Methods in 
molecular biology (Clifton, N.J.) 920, 101–109 (2012).
 82. Końca, K. et al. A cross-platform public domain PC image-analysis program for the comet assay. Mutation research 534, 15–20 
(2003).
 83. Odoni, D. I. et al. Comparative proteomics of Rhizopus delemar ATCC 20344 unravels the role of amino acid catabolism in fumarate 
accumulation. PeerJ 5, e3133 (2017).
 84. Pérez-Rubio, P., Lottaz, C. & Engelmann, J. C. FastqPuri: high-performance preprocessing of RNA-seq data. BMC Bioinformatics 20, 
226 (2019).
 85. Zerbino, D. R. et al. Ensembl 2018. Nucleic acids research 46, D754–D761 (2018).
 86. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
1 2Scientific RepoRtS |         (2020) 10:3232  | https://doi.org/10.1038/s41598-020-60101-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
 87. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic 
features. Bioinformatics 30, 923–930 (2014).
 88. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome 
Biology 15, 550 (2014).
 89. Maere, S., Heymans, K. & Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in 
Biological Networks. Bioinformatics 21, 3448–3449 (2005).
 90. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. 
Nucleic Acids Research 44, D457–D462 (2016).
 91. R Development Core Team, R. R: A language and environment for statistical computing. R Foundation for Statistical Computing, 
Vienna, Austria (2013).
 92. Wickham, H. Ggplot2: elegant graphics for data analysis. (Springer, 2009).
 93. Cherry, J. M. et al. Saccharomyces Genome Database: the genomics resource of budding yeast. Nucleic Acids Research 40, 
D700–D705 (2012).
Acknowledgements
This work was supported by the European Union’s H2020 research and innovation programme under the Marie 
Skłodowska-Curie grant agreements N° 691095 and N° 734873; and Junta de Castilla y Leon-FEDER under 
grants N° BU079U16, and N° UBU-16-B. We thank B. Domi for her invaluable assistance.
Author contributions
J.A.T.R. conceived and designed the work. J.A.T.R. and M.S.D. performed the experiments. J.A.T.R., M.S.D., F.L.T. 
and S.P. analysed and interpreted the data. J.A.T.R. and M.S.D. drafted the manuscript. J.A.T.R., M.S.D. and P.J.S. 
critically revised the manuscript for intellectual content. All authors have read and agree to the submission of the 
manuscript.
competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41598-020-60101-7.
Correspondence and requests for materials should be addressed to J.A.T.-R.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2020
